A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK.

Alexander T Cohen,Gary Benson,Charlotte A Bradbury,Satarupa Choudhuri,Nathan Hutchinson Jones,Anthony Maraveyas,Balaji Venugopal,Annie M Young, Chris Chapman, Shauna McIntyre, Danny Burney,Kevin G Pollock,Angharad R Morgan,Peter D Gabb,Raza Alikhan

Current medical research and opinion（2023）

引用 0|浏览9

暂无评分

摘要

Anticoagulant therapy for cancer-associated VTE patients should be carefully selected with consideration given to the relative benefits of specific drugs when individualizing care. Direct factor Xa inhibitors are typically the treatment of choice for preventing VTE recurrence in non-cancer patients and should also be considered as such for cancer-associated VTE in most situations.

查看译文

关键词

Anticoagulation,cancer-associated thrombosis,consensus,direct oral anticoagulant,venous thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要